Shares of T3 Defense Inc. (NASDAQ: DFNS) experienced a significant premarket surge on Monday, climbing 39.0% to $6.0452 as of 4:59 a.m. EDT. The jump comes amid heightened anticipation surrounding the company's Project35 acquisition agreement. Premarket trading volume reached approximately 2.45 million shares, a figure that dwarfs the company's post-split share count by a factor of 2.2 to 2.4 times.
The substantial volume underscores the market's intense focus on T3 Defense's strategic moves. The company's small share base, which stands at approximately 1.01 million shares as of July 6, amplifies the impact of each trade. This denominator effect also makes the financial commitments tied to Project35 appear particularly large relative to T3's market capitalization.
Project35 Deal Details
According to regulatory filings, the consideration and commitments related to Project35 represent between 71% and 78% of T3's premarket-implied equity value. This estimate is based on Monday's premarket quote of $6.0452 per share, which gives the company an implied equity value between $6.11 million and $6.76 million.
Key components of the Project35 package include a block of 168,479 shares issued to X S.E. Security and Defense and Elad Shohat, valued at approximately $1.02 million based on the premarket price. Additionally, T3 issued a $1.25 million note carrying a 12% interest rate and committed to investing an additional $2.5 million in Project35 over the next 12 months. Combined, these items total approximately $4.77 million.
Market Context and Implications
The premarket surge has increased T3's implied equity cushion, but it has not reduced the size of the Project35 commitment. The company's initial forecast for Project35 anticipates 2026 revenue near $2.4 million, compared to unaudited 2025 revenue of about $1.4 million. Chief Executive Menny Shalom stated that the acquisition places T3 "on both sides of that equation," citing roles in drones and their interception.
A Friday filing revealed that X Security and Shohat are in talks to sell another asset to T3, with payment under negotiation involving more common stock. No valuation has been provided for this potential additional transaction.
Stock Performance and Listing Compliance
The week following the reverse stock split saw significant volatility. On Monday, shares finished at $4.26, then climbed to $6.57 on Tuesday. Over the next three trading days, prices dropped sequentially to $4.70, $3.90, and $4.35. Trading volume on Tuesday hit 20.3 million shares, about 18 to 20 times the stated share-count range, reflecting high turnover.
T3 has closed above $1 for five consecutive sessions since July 20. If it maintains this streak for another five sessions through July 31, it will fulfill Nasdaq's minimum requirement of 10 consecutive sessions. Nasdaq is still required to provide T3 with a notice confirming compliance has been restored.
Financial Health and Risks
T3 posted revenue of $3.65 million for the first quarter and recorded an operating loss of $3.81 million. As of March 31, the company had $7.36 million in cash but used $4.9 million in operating activities during the quarter. The Project35 financing commitment represents approximately 34% of March cash, and factoring in the note lifts the figure to roughly 51%.
Management stated that its equity line and additional strategies are expected to finance the next year, but further share sales may dilute existing shareholders. Investors are monitoring two key figures: the $1 mark for listing compliance and the share count for both dilution and transaction size.
